Literature DB >> 20128641

Controversy: ocular sarcoidosis.

Denis Wakefield1, Manfred Zierhut.   

Abstract

The recent publication of diagnostic criteria for ocular sarcoidosis has renewed interest in this enigmatic and often controversial disease. The aim of the present review was to report on the results of a survey of leading ophthalmologists in which we asked them to address some of the most important issues related to the diagnosis and treatment of ocular sarcoidosis. The survey revealed that there is significant uptake and use of the diagnostic criteria for ocular sarcoidosis, although there still remained considerable differences in opinion with regard to whether or not this was an isolated condition affecting only the eye and how this should be diagnosed and appropriately managed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20128641     DOI: 10.3109/09273941003597276

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  5 in total

Review 1.  Cutting-edge issues in autoimmune uveitis.

Authors:  Roger A Levy; Francisco Assis de Andrade; Ivan Foeldvari
Journal:  Clin Rev Allergy Immunol       Date:  2011-10       Impact factor: 8.667

Review 2.  [Ocular sarcoidosis].

Authors:  C Springer-Wanner; T Brauns
Journal:  Z Rheumatol       Date:  2017-06       Impact factor: 1.372

Review 3.  Extrapulmonary manifestations of sarcoidosis.

Authors:  Deepak A Rao; Paul F Dellaripa
Journal:  Rheum Dis Clin North Am       Date:  2013-03-13       Impact factor: 2.670

Review 4.  Sarcoid Uveitis: An Intriguing Challenger.

Authors:  Pia Allegri; Sara Olivari; Federico Rissotto; Roberta Rissotto
Journal:  Medicina (Kaunas)       Date:  2022-07-04       Impact factor: 2.948

5.  Interleukin-2 Receptor and Angiotensin-Converting Enzyme as Markers for Ocular Sarcoidosis.

Authors:  Enken Gundlach; Michael Marcus Hoffmann; Antje Prasse; Sonja Heinzelmann; Thomas Ness
Journal:  PLoS One       Date:  2016-01-22       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.